Hydroxychloroquine

In the US, Hydroxychloroquine (hydroxychloroquine systemic) is a member of the following drug classes: antimalarial quinolines, antirheumatics and is used to treat Dermatomyositis, Malaria, Malaria Prevention, Rheumatoid Arthritis, Sjogren's Syndrome, Systemic Lupus Erythematosus and Undifferentiated Connective Tissue Disease.

US matches:

• Hydroxychloroquine


• Hydroxychloroquine Sulfate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P01BA02

CAS registry number (Chemical Abstracts Service)

0000118-42-3

Chemical Formula

C18-H26-Cl-N3-O

Molecular Weight

335

Therapeutic Categories

Disease-modifying antirheumatic drug, DMARD

Antiprotozoal agent: Antimalarial

Chemical Name

Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-

Foreign Names

• Hydroxychloroquinum (Latin)
• Hydroxychloroquin (German)
• Hydroxychloroquine (French)
• Hidroxicloroquina (Spanish)

Generic Names

• Hydroxychloroquine (OS: BAN)
• Idroxiclorochina (OS: DCIT)
• Oxychloroquine (IS)
• Win 1258-2 (IS)
• Hydroxychloroquine Sulphate (OS: BANM)
• Hydroxychloroquine Sulfate (PH: USP 32)
• Hydroxychloroquine Sulphate (PH: BP 2010)

Brand Names

• HCQS
  Medigroup, Peru



• Planil
  Medicon, Bangladesh



• Plaquenil
  Sanofi Aventis, Tunisia



• Polirreumin
  TRB, Argentina



• Apo-Hydroxyquine
  Apotex, Canada



• Axokine
  Rontag, Argentina



• Dimard
  Metlen, Colombia



• Dolquine
  Inmunosyn, Colombia; Rubio, Spain



• Ercoquin
  Medic, Denmark



• Evoquin
  Ivax, Argentina



• Gen-Hydroxychloroquine
  Genpharm, Canada



• Geniquin
  Genovate, Taiwan



• Hydroxychloroquine Sulfate
  Ipca, United States; Mylan, United States; Sandoz, United States; Teva USA, United States; Watson, United States; West-Ward, United States; Zydus, United States



• Metirel
  Pfizer, Argentina



• Narbon
  Buxton, Argentina



• Oxiklorin
  Orion, Finland



• Plaquenil
  Delphi, Netherlands; Sanofi-Aventis, Argentina; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Canada; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Denmark; Sanofi-Aventis, Estonia; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Georgia; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Ireland; Sanofi-Aventis, Israel; Sanofi-Aventis, Italy; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Malta; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Norway; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Sweden; Sanofi-Aventis, Singapore; Sanofi-Aventis, Thailand; Sanofi-Aventis, Taiwan; Sanofi-Aventis, United States; Sanofi-Synthelabo, Ghana; Sanofi-Synthelabo, Iceland; Sanofi-Synthelabo, Kenya; Sanofi-Synthelabo, Luxembourg; Sanofi-Synthelabo, Nigeria; Sanofi-Synthelabo, Romania; Sanofi-Synthelabo, Tanzania; Sanofi-Synthelabo, Uganda; Winthrop, Slovakia



• Plaquinol
  Biosaúde, Portugal; Sanofi-Aventis, Chile; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Venezuela; Sanofi-Synthelabo, Peru



• Quensyl
  Sanofi-Aventis, Germany



• Reconil
  Incepta, Bangladesh



• Reuquinol
  Apsen, Brazil

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.